DeepCure

Drug discovery with AI.

Edited:

📋 Overview of DeepCure

Founding Year

2018

Estimated Funding

$0000

Size

$0000

Locations

Boston

Primary Industry

Pharmaceuticals

📙 About DeepCure

DeepCure is an AI drug development platform that accelerates the discovery and development of new medications, reducing time-to-market. It automates complex processes and enhances precision to help researchers identify promising compounds faster and more accurately, leading to better patient outcomes.

💰 Recent Investors of DeepCure

5Y Capital, Benon Group, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.